000			01802 a2200469 4500
005			20250515223425.0
264		0	_c20110309
008			201103s 0 0 eng d
022			_a1532-2513
024	7		_a10.3109/08923971003671082 _2doi
040			_aNLM _beng _cNLM
100	1		_aWright, Stephen E
245	0	0	_aRetention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions. _h[electronic resource]
260			_bImmunopharmacology and immunotoxicology _cDec 2010
300			_a647-55 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAmino Acid Substitution _ximmunology
650	0	4	_aBreast Neoplasms _ximmunology
650	0	4	_aCell Line, Tumor
650	0	4	_aCytokines _xmetabolism
650	0	4	_aCytotoxicity Tests, Immunologic
650	0	4	_aCytotoxicity, Immunologic _ximmunology
650	0	4	_aFemale
650	0	4	_aGlycosylation
650	0	4	_aHIV Envelope Protein gp120 _ximmunology
650	0	4	_aHumans
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aKiller Cells, Lymphokine-Activated _ximmunology
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aLeukocytes, Mononuclear _xdrug effects
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMinisatellite Repeats _xgenetics
650	0	4	_aMucin-1 _xgenetics
650	0	4	_aPeptide Fragments _xgenetics
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
700	1		_aQuinlin, Imelda S
700	1		_aRewers-Felkins, Kathleen A
700	1		_aDombrowski, Ken E
700	1		_aPhillips, Catherine A
773	0		_tImmunopharmacology and immunotoxicology _gvol. 32 _gno. 4 _gp. 647-55
856	4	0	_uhttps://doi.org/10.3109/08923971003671082 _zAvailable from publisher's website
999			_c19824579 _d19824579